Don't want ads? Click here
Don't want ads? Click here
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Latest Finance & Stock Market News
(Alliance News) - Ruffer Investment Co Ltd on Wednesday reported an improved total return in 2025, as its founder, Jonathan Ruffer, prepares to retire after three decades at the helm.
1 Oct 2025 09:07
Indices
| Indices | Value | Chg | % |
|---|---|---|---|
| FTSE 100 | 9,446.43 | 96.00 | 1.03% |
| FTSE 250 | 22,049.70 | 34.14 | 0.16% |
| FTSE 350 | 5,163.29 | 47.32 | 0.92% |
| FTSE All-Share | 5,108.07 | 46.34 | 0.92% |
| FTSE Small Cap | 7,291.18 | 20.66 | 0.28% |
Market Bulletins
- London midday: Stocks extend gains as pharmaceuticals rally [Wed 10:47]
- London open: FTSE edges up as pharmas rally; US govt shutdown in focus [Wed 08:37]
- London close: FTSE hits another record high as pharma stocks rally [Wed 07:40]
- London pre-open: Stocks to dip as US government shuts down [Wed 07:29]
- London midday: FTSE flat as investors mull potential US govt shutdown [Tue 11:13]
Latest Financial News
- IN BRIEF: Wellnex Life names Ash Vesali as interim executive chair
- IN BRIEF: IG Group CEO Breon Corcoran buys GBP800,000 worth of shares
- UK's Labour government plans permanent fracking ban
- LONDON MARKET CLOSE: Drug stocks help send FTSE 100 to new record high
- Daiichi and AstraZeneca's breast cancer therapy accepted for US review
Most Traded on Thursday 2nd October
| Company | Price | Value | Trades |
|---|---|---|---|
| Rolls-Royce (RR.) | 1,177.00 | £334,136.39k | 154,791 |
| International Airlines (IAG) | 379.40 | £56,341.32k | 107,742 |
| Astrazeneca (AZN) | 12,436.00 | £528,836.69k | 47,621 |
| Glaxosmithkline (GSK) | 1,671.50 | £356,209.92k | 22,422 |
| BP (BP.) | 427.75 | £142,689.05k | 21,832 |
| Company | Price | Value | Volume |
|---|---|---|---|
| Astrazeneca (AZN) | 12,436.00 | £528,836.69k | 4,371,301 |
| HSBC Holdings (HSBA) | 1,050.80 | £399,709.27k | 39,205,485 |
| London Stock Exchange (LSEG) | 8,636.00 | £383,926.35k | 5,142,845 |
| Glaxosmithkline (GSK) | 1,671.50 | £356,209.92k | 22,095,384 |
| Rolls-Royce (RR.) | 1,177.00 | £334,136.39k | 28,619,741 |
Sector Activity
Top Rising Industry Sectors
| Medicine and Biotech | 8.65% |
| Industrial Engineering | 1.53% |
| Industrial Chemicals | 1.43% |
| Electricity Generation and Distribution | 1.33% |
| Finance Services | 1.30% |
Top Falling Industry Sectors
| Leisure Goods | -2.28% |
| Food Products | -2.11% |
| Health Care and Related Services | -1.81% |
| Software and Computing | -1.47% |
| Tobacco | -1.29% |
Harena Resources: Further Investment from RAB Capital and associates
The Board of Harena Resources Plc (LSE: HREE), the rare earths company focused on the Ampasindava ionic clay rare earth project in Madagascar (the "Ampasindava Project"), is pleased to announce...
My Club Expands into Europe to Power Grassroots Sports Across Ireland, France, Spain and Germany
Graham Anderson, My Club's (MCE) Head of International Management, said; "This expansion means more European clubs can reduce the time, cost and complexity of sourcing kit."Our platform gives them...
Adrian Hargrave, CEO of SEEEN, explains how they achieved 87% increase in revenue
Interim results to June 2025 from global AI media and technology platform SEEEN Plc (AIM:SEEEN) reveal an 87% increase in revenues with in excess of $5m revenues expected for FY25.In this interview...
Featured Investment Trust
Allianz Technology Trust PLC (ATT)
Strives for superior long-term returns by identifying major trends ahead of the crowd and participating in stocks that have the potential to become tomorrow's Microsoft, Google or Apple. The portfolio tends to be overweight in high growth mid cap companies and underweight in mega cap companies. The Manager continues to exploit the considerable benefits of being located in San Francisco and has close and regular contact with the growth companies that are identified for the portfolio.
Find Out More
